Asherman’s Syndrome

Asherman’s Syndrome is an acquired uterine condition characterized by the formation of fibrous bands (synechiae) or adhesions within the uterine cavity. These bands can partially or completely obliterate the cavity, leading to secondary amenorrhea, cyclic pelvic pain, and infertility.

The primary cause is trauma to the uterine lining (endometrium), most commonly following dilation and curettage (D&C) performed for pregnancy-related complications (e.g., miscarriage, postpartum hemorrhage, retained products of conception). Genetic factors are minimal; it is essentially a condition of impaired regenerative healing following injury.

Injury to the basal layer of the endometrium triggers an inflammatory response. If the regenerative capacity of the stem cells in the basalis layer is destroyed, the apposing walls of the uterus undergo fibrous fusion. This results in the obliteration of the cavity, restriction of surface area for blastocyst implantation, and obstruction of cervical os outflow.

Prevalence is difficult to quantify but is estimated at 1.5%–20% in women undergoing D&C post-miscarriage. It disproportionately affects women of reproductive age who have undergone uterine surgical procedures.

• Repeated D&C procedures
• Cesarean section complications
• Myomectomy
• Endometrial infection (e.g., untreated tuberculosis or chronic endometritis)
• Uterine artery embolization

A. Early Symptoms

• Hypomenorrhea (decreased menstrual flow)


• Mild pelvic discomfort B. Common Symptoms


• Secondary amenorrhea


• Infertility


• Recurrent pregnancy loss C. Advanced Symptoms


• Cyclic pelvic pain (hematometra due to outflow obstruction)


• Dysmenorrhea D. Emergency Symptoms


• Acute, severe pelvic pain


• Sepsis (if associated with hematometra)

Generally unremarkable. During speculum exam, the cervix may appear normal; however, bimanual palpation may reveal a slightly tender uterus if hematometra is present.

A. Clinical Assessment: History of uterine surgery followed by menstrual changes.
B. Laboratory Testing: Rule out hormonal causes (FSH, LH, Prolactin, TSH).
C. Imaging Studies: Transvaginal Ultrasound (TVS), Hysterosalpingography (HSG), and Hysteroscopy (gold standard).
D. Functional Tests: Not applicable.
E. Biopsy Findings: Fibrotic connective tissue, lack of normal endometrial architecture.
F. Genetic Testing: Not indicated.
G. Differential Diagnosis: Primary ovarian insufficiency, hypothalamic amenorrhea, endometrial atrophy.

Test Name: Serum Beta-hCG
Type: Blood Test
Purpose: Exclude pregnancy
Expected Findings: Negative
Interpretation: Rules out gestational etiology. Test Name: FSH/LH/Estradiol Panel
Type: Blood Test
Purpose: Rule out hormonal amenorrhea
Expected Findings: Normal
Interpretation: Confirms uterine, not endocrine, cause.

• Hysteroscopy: Visualization of adhesions (Gold standard).
• Hysterosalpingography (HSG): Filling defects in the uterine cavity.
• Sonohysterography: Improved visualization of endometrial lining thickness.

• Asherman's vs. Endometrial Atrophy: Atrophy lacks the mechanical obstruction/fibrosis seen in Asherman's.
• Asherman's vs. Pituitary Amenorrhea: Pituitary causes have abnormal FSH/LH levels.

• Placenta accreta (due to abnormal implantation site)
• Recurrent miscarriage
• Preterm labor
• Intrauterine growth restriction (IUGR)

A. Lifestyle Modifications: Weight optimization to support hormonal balance.
B. Preventive Measures: Avoid unnecessary D&C; use ultrasound-guided suction curettage.
C. Medical Treatment

• Estrogen Therapy: Promotes endometrial proliferation.


• Progestins: Used to induce withdrawal bleeds.


• Antibiotics: If infection is present.

Good for mild cases; success rates for fertility decrease as the severity of adhesions increases. Menstrual regularity is often restored, but repeat procedures are frequently necessary.

Perform ultrasound-guided procedures; use medical management (misoprostol) for early pregnancy loss instead of surgery when appropriate.

The following homeopathic remedies have been historically indicated for symptoms associated with Asherman’s Syndrome. Selection should be based on individualized symptom totality and constitutional assessment.

• Homeopathy by Hadhrat Mirza Tahir Ahmad (r.a.) — Primary clinical reference
• Robin Murphy — Lotus Materia Medica (3rd Edition)
• William Boericke — Pocket Manual of Homœopathic Materia Medica & Repertory
• ICD-10/ICD-11 Classification — World Health Organization
• Harrison's Principles of Internal Medicine (Reference Standard)

This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.

🔬 Lab Report Analyzer (Diagnostic Verification)

Upload your laboratory bloodwork PDF or paste your report text to automatically extract markers, detect units, and identify reference range variances related to Asherman’s Syndrome.